Induction of differentiation in endogenous progenitor cells

The term "Induction of differentiation in endogenous progenitor cells" refers to a therapeutic strategy or process intended to stimulate tissue-resident (endogenous) progenitor or stem cells to differentiate into mature, specialized cell types for tissue repair, regeneration, or restoration of lost function. Endogenous progenitor cells are present in many tissues and are capable of differentiating into specific cell types under appropriate signals. Strategies to induce their differentiation include delivery of growth factors, modulation of the immune microenvironment, or use of small molecules to inhibit pathways that suppress differentiation. This approach is fundamental to regenerative medicine and may be relevant to the treatment of a wide variety of diseases and injuries, including those involving the muscle, bone, neural, inner ear, pancreatic, and lung tissues. However, it is not a singular molecular target but rather a broad therapeutic concept encompassing numerous signaling pathways and molecular effectors. As such, it cannot be directly classified as a molecule, receptor, or drug target[1][2][4][5]. There is no canonical molecule or receptor corresponding to this process—rather, multiple factors and pathways (such as growth factors, cytokines, immune modulators) can induce differentiation depending on tissue context. This entry is therefore not a correct or specific target designation[1][2][4][5].

Other names

activation of endogenous progenitor cell differentiationstimulation of tissue regeneration via endogenous stem/progenitor cellsprogenitor cell differentiation induction

Promotion of differentiation by changing local microenvironment (cytokines, growth factors); Suppression of inhibitory signals (e.g. inhibition of IL-1R1, NF-κB, MyD88 signaling); Cell signaling modulation to enhance differentiation and tissue repair